$14.46
-1.31-8.31%
Last update: Oct 30, 6:34 PM
Generate Biomedicines Inc
GENBNASDAQ
Generate Biomedicines (GENB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.49 | $-0.48 |
| Actual | $-0.52 | $-1.07 |
| Surprise | -6.12% | -122.9% |
| Revenue | ||
| Estimate | $5.5M | $6.0M |
| Actual | $6.3M | $7.2M |
| Surprise | +14.3% | +19.6% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.54 | $-0.56 | $-0.55 | $-0.53 |
| Revenue | ||||
| Consensus | $7.8M | $7.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.52 | $-0.49 | -6.12 % |
| Q1 | May 7, 2026 | $-1.07 | $-0.48 | -122.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $6.31M | $5.52M | 14.3 % |
| Q1 | May 7, 2026 | $7.22M | $6.04M | 19.6 % |
